Last €8.01 EUR
Change Today +0.01 / 0.13%
Volume 1.0
As of 3:00 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

median technologies (ALMDT) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/12/14 - €9.15
52 Week Low
02/24/15 - €7.61
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

median technologies (ALMDT) Related Businessweek News

No Related Businessweek News Found

median technologies (ALMDT) Details

MEDIAN Technologies S.A. provides medical imaging products and integrated services for diagnosing and monitoring cancer patients in routine clinical practice and clinical drug development. The company’s products include MEDIAN CTIS, a change paradigm for image interpretation and management; and lesion management solutions for diagnosing and treating cancer patients. It also offers lung cancer screening imaging, clinical trial imaging, and managed services, as well as companion and monitoring tests. MEDIAN Technologies S.A. has strategic partnership with Canon, Inc.; Kuwait Life Science Company; and Quintiles. The company was founded in 2002 and is based in Valbonne, France.

47 Employees
Last Reported Date: 05/28/14
Founded in 2002

median technologies (ALMDT) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

median technologies (ALMDT) Key Developments

MEDIAN Technologies to Provide Imaging Solutions and Services for New Phase III Study

MEDIAN Technologies announced that it has been selected to provide imaging solutions and services for a new Phase III study, conducted by a European biopharmaceutical company. The project awarded to MEDIAN pertains to a clinical trial on non-small cell lung cancer, and will represent approximately EUR 2.2 million for MEDIAN. With this project, scheduled to start before the end of 2014.

MEDIAN Technologies S.A. Reports Audited Earnings Results for the First Half Ended June 30, 2014

MEDIAN Technologies S.A. reported audited earnings results for the first half ended June 30, 2014. For the period, the company reported total income of EUR 697,000 against EUR 548,000 a year ago. Total operating income was EUR 728,000 against EUR 646,000 a year ago. Operating profit was EUR 2,220,000 against EUR 2,428,000 a year ago. Net profit was EUR 2,219,000 against EUR 2,134,000 a year ago.

MEDIAN Technologies Announces New Project Awards and a New Contract for a Total of EUR 1.58 million

MEDIAN Technologies announced that it has been selected to provide imaging solutions and services for three new studies, sponsored by global pharmaceutical companies and an Asian biotechnology company. These new studies represent approximately EUR 1.4 million in project awards and EUR 180,000 in signed contracts, for a total of EUR 1.58 million. Two of these studies are sponsored by historical clients of MEDIAN Technologies, one of which will base its Go/No Go decision for a later clinical phase on MEDIAN's implementation of an advanced imaging biomarker. Together, these studies will involve more than 280 clinical sites across the world. Studies will start over a period running from the fourth quarter of 2014 to fourth quarter of 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALMDT:FP €8.01 EUR +0.01

ALMDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
MGT Capital Investments Inc $0.60 USD +0.0823
View Industry Companies

Industry Analysis


Industry Average

Valuation ALMDT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIAN TECHNOLOGIES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at